Specific RNA m6A modification sites in bone marrow mesenchymal stem cells from the jawbone marrow of type 2 diabetes patients with dental implant failure

Abstract The failure rate of dental implantation in patients with well-controlled type 2 diabetes mellitus (T2DM) is higher than that in non-diabetic patients. This due, in part, to the impaired function of bone marrow mesenchymal stem cells (BMSCs) from the jawbone marrow of T2DM patients (DM-BMSCs...

Full description

Bibliographic Details
Main Authors: Wanhao Yan, Xiao Lin, Yiqian Ying, Jun Li, Zhipeng Fan
Format: Article
Language:English
Published: Nature Publishing Group 2023-01-01
Series:International Journal of Oral Science
Online Access:https://doi.org/10.1038/s41368-022-00202-3
_version_ 1797952646529679360
author Wanhao Yan
Xiao Lin
Yiqian Ying
Jun Li
Zhipeng Fan
author_facet Wanhao Yan
Xiao Lin
Yiqian Ying
Jun Li
Zhipeng Fan
author_sort Wanhao Yan
collection DOAJ
description Abstract The failure rate of dental implantation in patients with well-controlled type 2 diabetes mellitus (T2DM) is higher than that in non-diabetic patients. This due, in part, to the impaired function of bone marrow mesenchymal stem cells (BMSCs) from the jawbone marrow of T2DM patients (DM-BMSCs), limiting implant osseointegration. RNA N6-methyladenine (m6A) is important for BMSC function and diabetes regulation. However, it remains unclear how to best regulate m6A modifications in DM-BMSCs to enhance function. Based on the “m6A site methylation stoichiometry” of m6A single nucleotide arrays, we identified 834 differential m6A-methylated genes in DM-BMSCs compared with normal-BMSCs (N-BMSCs), including 43 and 790 m6A hypermethylated and hypomethylated genes, respectively, and 1 gene containing hyper- and hypomethylated m6A sites. Differential m6A hypermethylated sites were primarily distributed in the coding sequence, while hypomethylated sites were mainly in the 3′-untranslated region. The largest and smallest proportions of m6A-methylated genes were on chromosome 1 and 21, respectively. MazF-PCR and real-time RT-PCR results for the validation of erythrocyte membrane protein band 4.1 like 3, activity-dependent neuroprotector homeobox (ADNP), growth differentiation factor 11 (GDF11), and regulator of G protein signalling 2 agree with m6A single nucleotide array results; ADNP and GDF11 mRNA expression decreased in DM-BMSCs. Furthermore, gene ontology and Kyoto Encyclopedia of Genes and Genomes analyses suggested that most of these genes were enriched in metabolic processes. This study reveals the differential m6A sites of DM-BMSCs compared with N-BMSCs and identifies candidate target genes to enhance BMSC function and improve implantation success in T2DM patients.
first_indexed 2024-04-10T22:50:45Z
format Article
id doaj.art-b78464c559b64f9fb4b528b382604777
institution Directory Open Access Journal
issn 2049-3169
language English
last_indexed 2024-04-10T22:50:45Z
publishDate 2023-01-01
publisher Nature Publishing Group
record_format Article
series International Journal of Oral Science
spelling doaj.art-b78464c559b64f9fb4b528b3826047772023-01-15T12:05:52ZengNature Publishing GroupInternational Journal of Oral Science2049-31692023-01-0115111310.1038/s41368-022-00202-3Specific RNA m6A modification sites in bone marrow mesenchymal stem cells from the jawbone marrow of type 2 diabetes patients with dental implant failureWanhao Yan0Xiao Lin1Yiqian Ying2Jun Li3Zhipeng Fan4Laboratory of Molecular Signaling and Stem Cells Therapy, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Capital Medical University School of StomatologyDepartment of Dental Implant Center, Beijing Stomatological Hospital, School of Stomatology, Capital Medical UniversityDepartment of Oral Implantology, Tianjin Stomatological Hospital, School of Medicine, Nankai UniversityDepartment of Dental Implant Center, Beijing Stomatological Hospital, School of Stomatology, Capital Medical UniversityLaboratory of Molecular Signaling and Stem Cells Therapy, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Capital Medical University School of StomatologyAbstract The failure rate of dental implantation in patients with well-controlled type 2 diabetes mellitus (T2DM) is higher than that in non-diabetic patients. This due, in part, to the impaired function of bone marrow mesenchymal stem cells (BMSCs) from the jawbone marrow of T2DM patients (DM-BMSCs), limiting implant osseointegration. RNA N6-methyladenine (m6A) is important for BMSC function and diabetes regulation. However, it remains unclear how to best regulate m6A modifications in DM-BMSCs to enhance function. Based on the “m6A site methylation stoichiometry” of m6A single nucleotide arrays, we identified 834 differential m6A-methylated genes in DM-BMSCs compared with normal-BMSCs (N-BMSCs), including 43 and 790 m6A hypermethylated and hypomethylated genes, respectively, and 1 gene containing hyper- and hypomethylated m6A sites. Differential m6A hypermethylated sites were primarily distributed in the coding sequence, while hypomethylated sites were mainly in the 3′-untranslated region. The largest and smallest proportions of m6A-methylated genes were on chromosome 1 and 21, respectively. MazF-PCR and real-time RT-PCR results for the validation of erythrocyte membrane protein band 4.1 like 3, activity-dependent neuroprotector homeobox (ADNP), growth differentiation factor 11 (GDF11), and regulator of G protein signalling 2 agree with m6A single nucleotide array results; ADNP and GDF11 mRNA expression decreased in DM-BMSCs. Furthermore, gene ontology and Kyoto Encyclopedia of Genes and Genomes analyses suggested that most of these genes were enriched in metabolic processes. This study reveals the differential m6A sites of DM-BMSCs compared with N-BMSCs and identifies candidate target genes to enhance BMSC function and improve implantation success in T2DM patients.https://doi.org/10.1038/s41368-022-00202-3
spellingShingle Wanhao Yan
Xiao Lin
Yiqian Ying
Jun Li
Zhipeng Fan
Specific RNA m6A modification sites in bone marrow mesenchymal stem cells from the jawbone marrow of type 2 diabetes patients with dental implant failure
International Journal of Oral Science
title Specific RNA m6A modification sites in bone marrow mesenchymal stem cells from the jawbone marrow of type 2 diabetes patients with dental implant failure
title_full Specific RNA m6A modification sites in bone marrow mesenchymal stem cells from the jawbone marrow of type 2 diabetes patients with dental implant failure
title_fullStr Specific RNA m6A modification sites in bone marrow mesenchymal stem cells from the jawbone marrow of type 2 diabetes patients with dental implant failure
title_full_unstemmed Specific RNA m6A modification sites in bone marrow mesenchymal stem cells from the jawbone marrow of type 2 diabetes patients with dental implant failure
title_short Specific RNA m6A modification sites in bone marrow mesenchymal stem cells from the jawbone marrow of type 2 diabetes patients with dental implant failure
title_sort specific rna m6a modification sites in bone marrow mesenchymal stem cells from the jawbone marrow of type 2 diabetes patients with dental implant failure
url https://doi.org/10.1038/s41368-022-00202-3
work_keys_str_mv AT wanhaoyan specificrnam6amodificationsitesinbonemarrowmesenchymalstemcellsfromthejawbonemarrowoftype2diabetespatientswithdentalimplantfailure
AT xiaolin specificrnam6amodificationsitesinbonemarrowmesenchymalstemcellsfromthejawbonemarrowoftype2diabetespatientswithdentalimplantfailure
AT yiqianying specificrnam6amodificationsitesinbonemarrowmesenchymalstemcellsfromthejawbonemarrowoftype2diabetespatientswithdentalimplantfailure
AT junli specificrnam6amodificationsitesinbonemarrowmesenchymalstemcellsfromthejawbonemarrowoftype2diabetespatientswithdentalimplantfailure
AT zhipengfan specificrnam6amodificationsitesinbonemarrowmesenchymalstemcellsfromthejawbonemarrowoftype2diabetespatientswithdentalimplantfailure